Loading Events

European Prefilled Syringes Summit 2017

Date: 6th September 2017 - 7th September 2017 Location: Berlin - Germany

After the success of our first European Prefilled Syringes Summit, we are pleased to announce the next edition which shall take place on the 6th & 7th September in Berlin, Germany.

The global market for pre-filled syringes will grow substantially over the next five years to reach sales of $6.6 billion, according to a new report from Smithers Rapra. With sales of $6.9 billion expected by 2018, syringes of this kind cater to an expanding patient demographic: people with chronic conditions who need, or prefer, to administer their own medicines. The race is on to improve the associated technologies, ensuring that the new generation of prefilled syringes can adequately accommodate tomorrow’s drugs.

Biopharmaceutical packaging is changing. As pharmaceutical manufacturers embrace more flexible processes that limit the risk of product contamination, packaging and containment systems are being designed to facilitate manufacturing of smaller product lots and batches. Some fill/finish operations are moving to fully enclosed, automated operation, requiring the use of not only nested syringes and closures, but also nested vials and caps, and manufacturers are working to standardize these components. Designers of primary packaging and delivery system components have had to change their approach to product development.

ACI’s European Prefilled Syringes Summit will explore the advancements in regulatory guidelines, product development, manufacturing processes, risk mitigation , portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes. . There are several elements that pose a severe challenge to the growth of the global prefilled syringes market, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables, the potential risk of interaction between prefilled syringes and drugs, and needle stick prevention.

If you would like to be considered as a speaker for the event with a 30-45 minute presentation, please submit an abstract for consideration to:

Chloe Wates
Tel: +44 (0)20 3141 0638
Email: cwates@acieu.net

 

Tickets

European Prefilled Syringes Summit - Conference Pass (Inc. Documentation Package)£1,275.00After £320 Early Bird Discount - Full Conference Pass. Standard Price £1595
European Prefilled Syringes Summit - Documentation Package Only£420.00

Details

Start:
6th September 2017
End:
7th September 2017
Event Category:

Contact

Name:
Mohammad Ahsan – Marketing, Delegate Sales & Media Partnerships
Phone:
+44 (0) 203 141 0606
Email:
Name:
Chloe Wates – Content
Phone:
+44 (0)20 3141 0638
Email:
Name:
Timothy Rowley-Evans – Sponsorship
Phone:
+442031410637
Email:
Name:
Claire Taylor-Payne – Logistics
Phone:
+ 44 (0)20 3141 0601
Email:

Venue

We will confirm the venue approximately 4-6 weeks before the event to ensure we find the most suitable space because numbers can vary dramatically. There will be a discounted accommodation rate for conference attendees.
Berlin, Germany
+ Google Map

European prefilled syringes market & growth opportunities

  • The evolving state of the market with respect to key players and geographies
  • Trends in modern biologics targeting therapeutic classes of drugs that are considered to be the primary growth drivers within the market
  • Lessons learned and latest market needs for PFS
  • Are next generation device factors such as connectivity & sustainability driving new demands?
  • Latest FDA guidelines
  • Inspection trends, and usability studies
  • Anti-counterfeit strategies

Regulatory Trends 

  • Latest Regulatory Submission Strategies & Overcoming Complex Requirements for Approval
  • Device related changes in the EU
  • Quality culture from a regulatory perspective
  • Microneedles and the latest transdermal delivery systems
  • Specialty syringes, which include prefilled flush syringes, prefilled diluent systems and contrast agents in prefilled syringe
  • Inspection trends, and usability studie
  • Anti-counterfeit strategies
  • Speed to market and complex product manufacturing
  • Minimizing interaction between theclosure system and the drug formulation
  • Technical collaborative success case study: product overview

Concentrating on Next Generation Smart Devices while Overcoming Traditional Challenges

  • Smart devices: their emerging role in auto-injector systems & driving innovation
  • Improving quality, connectivity, and cost control for combination products & autoinjector
  • Patient engagement and adherence -compliance with new products requires constant engagement with the target patient population and other applicable stakeholders throughout the design and commercialization
  • Overcoming technical challenges for building connectivity and sensors into new devices

The Drug/Device interface 

  • initegration of the formulation and the device

Device development and manufacturing

  • Next Generation Materials & Design of Pre-Filled Syringes
  • Usability: Key Human Factor Attributes & Interactive Considerations
  • The challenges of product classes
  • Patient Centric Design Updates for Pre-Filled Syringe applications
  • Challenges of paediatric drug delivery & Injectability of highly concentrated protein formulations
  • Managing the Materials used to Construct Pre-Filled Syringes—Selection and Supply Chain Control

Business development and marketing

  • Balancing biopharmaceutical product portfolio for continual product innovation, such as incorporating a new delivery component and Creating a lower-risk product development strategy
  • Improving Safety Standards Driving High Costs Associated with Prefilled Syringes Inhibiting widespread Adoption – Best practices in cost control
  • Driving quality & commercial competitiveness
  • Increasing demand for single use & reusable devices
  • Patient engagement and adherence -compliance with new products requires constant engagement with the target patient population and other applicable stakeholders throughout the design and commercialization

The two day event will provide an unique platform for collaboration and discussion between a variety of industry perspectives including manufacturers, suppliers, academia and regulators homing in on the latest opportunities arising from the prefilled syringes industry.

The aim is to identify potential solutions, future work programmes and productive partnerships that overcome the key regulatory challenges and facilitate minimizing risk within the supply chain promoting access to safe and effective biologicals.

  • Demonstrate how big data can be applied to design and
    optimize manufacturing processes
  • Define strategies to accelerate new products to the market
  • Interpret the latest trends in microbiological and adventitious
    agent control strategies
  • Explain delivery system design and manufacturing logistics for
    patient-centered therapies and precision medicine
  • Learn how devices serve the disease space by category
  • Summarize best practices for identifying and introducing new
    technologies

Andrew Feilden, Chemistry Operations Director, Smithers Rapra

Nan Yung Lin, Manager Drug Product Technology, Regeneron Pharmacueticals

Dr. Nicolas Brandes, Director Market Development Europe & Asia Pacific, West Pharmaceuticals 

Uwe Diegel, CEO, Lifena & Healthworks

Matteo Falgar, Buissness Dvelopment, Nipro Europe

Valerie Fenster, Senior Human Factors Engineering, Amgen

TBC, Sterisys Sàrl

 

If you would like to be considered as a speaker for the event with a 30-45 minute presentation, please submit an abstract for consideration to:


Chloe Wates

Tel: +44 (0)20 3141 0638

Email: cwates@acieu.net

Senior management within R&D:

  • Academics and Innovators
  • National and International Regulators and public health organisations
  • Policy makers and funding agencies.
  • Materials Suppliers
  • Pre-Filled Syringes/ Device Development
  • Product Management
  • Application Specialists
  • Senior Packaging Engineers
  • Advisory Consultants
  • Finished Products and Medical Devices
  • Device and Delivery Injectables

logo_sterisys_cmyk_300dpi

STERISYS is a young and dynamic company offering an outstanding solution portfolio in two different domains: Industrial Sterilisation Equipment and Automatic Handling Systems for Pre-filled Syringes.

STERISYS is European market leader in the area of industrial sterilisation with their leading technology and advanced solutions designed for the medical devices producers and contract sterilisation organisations. STERISYS is not a mere manufacturer but a systems integrator supplying turnkey solutions. Their holistic approach towards sterilisation systems is what differentiates them from other players in the industry.

In the industrial pharmaceutical sector, STERISYS develops, markets and supplies Krysalid®, an innovative solution to resolve the problems encountered with handling, transfer and transport of nest-and-tub pre-fillable syringes.

The Krysalid® system does not focus on a specific application for automation, but in finding a global solution to handle nest-and-tub configured products. Pre-fillable systems are usually very difficult and tedious to handle manually. They are applied in multiple situations (transfer to working stations, inspection machines, terminal sterilisers, etc.) and have slightly different shapes depending on the manufacturer. The solution to all these variables is based on combining the nest-and-tub support elements with specific patented devices to facilitate the interface with both humans and robots. By using these devices, the handling operation is gentle and the products (syringes, vials) will be safe from risk.

The emergence of a new player like STERISYS in the Pre-Filled Syringes domain, in close cooperation with the syringe manufacturers, drug manufacturers and equipment suppliers, will offer a world of new possibilities to achieve the growth expectations within this industry.

www.sterisys.eu

 


ACI has put together a range of packages to suit your requirements. These range from branding options, to full scale partner solutions and can be tailored to meet your objectives and budgets.

If you are launching a new product or service and wish to gain visibility and brand recognition within your industry, contact us today!

For commercial opportunities, please contact:


Tim Rowley-Evans

Tel: +44 20 3141 0637

Email: trowleyevans@acieu.net

IPI-logo

IPI – International Pharmaceutical Industry

IPI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable them to be more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.

We have established a strong presence in the US, Central Europe, Middle East, Latin America, Eastern Europe, Asia and Africa which are becoming increasingly important to the way the industry is moving forward in areas of Research and Development, Trials, Manufacturing and Technology Transfer.

http://www.ipimedia.com/


Swiss Biotech copy

Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals.  The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ – the global brand for the industry.

http://www.swissbiotech.org/


 

Gate2Biotech

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology.

Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad.

http://www.gate2biotech.com/


pharmavision_logo (Conference)

PharmaVision offers a consultancy service providing high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. We develop market models to forecast the potential growth of key developmental products and technologies and assess the challenges and opportunities which surround this specialist sector. We will also undertake in-depth interviews with key opinion leaders and generate slide decks for conferences and corporate meetings. For further information visit our website www.pharmavision.co.uk or contact Cheryl on +44 (0) 1243 785496 or via email Info@pharmavision.co.uk


 

CBSALOGO

Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio  and mobile digital health companies, research and academic institutions and service providers.

Link: http://www.cobioscience.com/


 

TN_Hi-res_Dark

Technology Networks has been established for over 10 years and is now the leading provider of free information services for life science professionals. This includes news, events, posters, videos, webcasts, application notes, new products, a literature search engine and product directories.  The information is specifically tailored to over 30 individual communities with specific interests, all of which can be accessed through TechnologyNetworks.com.

http://www.technologynetworks.com/


Farmavita-logo-exp

FarmavitaR+ is the professional network of  regulatory affairs  consultants. FarmavitaR+ is not just a pure internet portal. We manage team  of local associates with expertise in national legislation related to pharmaceutical regulatory affairs practice. FarmavitaR+ is brand name owned by FARMAVITA REGULANET d.o.o. Compnay was established as joint venture of Farmavita d.o.o. and Regulanet Ag.

The company profiled itself to be the top service provider in  regulatory affairs, in central-east and south-east Europe. We are currently employing a few people in Croatia and the network of associates in Czech R, Slovak R., Hungary, Serbia, Bosnia and Herzegovina, FYR Macedonia, Bulgaria, Romania and Turkey.


Web Packaging

Webpackaging, part of the Webpac Digital Media Group’s suite of online services, is the best global platform available for connecting packaging buyers with packaging suppliers. It is the packaging industry’s most powerful search engine scanning news, products, specifications, web sites, documents, videos, and more. The site contains 10,000+ comprehensive company portals with over one million pages of tagged content and features the 3D Design Studio, Packaging Catalogs, Packaging Maps, Packaging Trends and Innovations, Packaging Events, and more.

Webpackaging is where successful brands source packaging.

http://www.webpackaging.com/ 


SelectScience - European Prefilled Syringes Summit

SelectScience is an independent, online review resource for the worldwide scientific community, and the fastest way to impartial, expert opinion about the latest laboratory equipment and techniques. Discover new technologies, products and trusted reviews; plus videos, application notes and the latest science news from around the world. Become a member for free today: http://www.selectscience.net/


PharmaVOICE-Web

PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

Link: http://www.pharmavoice.com


BioChem Adda Logo

BioChem Adda aims to provide the most reliable information portal related to biotech jobs, biotech internships, careers, education, fellowships, news, articles, and events from the field of Biological and Chemical Sciences!

URL: https://www.biochemadda.com


Drug Discovery Today

Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, written by experts in their respective fields and cover all aspects of drug discovery from state-of-the-art genomic and proteomic approaches to target identification, through the most innovative computational approaches drug design, the science driving medicinal chemistry and the translation of these sciences to therapies.

Link: http://www.drugdiscoverytoday.com/


Pharma Marketing News

Pharma Marketing Network® is owned and operated by VirSci Corporation, a pharmaceutical publishing company, which was established in 1995 by John Mack (aka Pharmaguy).
VirSci has long been a pioneer in developing and managing pharmaceutical marketing Web sites and email-based discussion groups. In 1995, for example, VirSci launched PharmInfoNet, a “Top 20 Health Site” focused on drug information content and databases for physicians and pharmacists. PharmInfoNet pioneered many innovative, Internet-based communication programs including the Electronic Highlights Bulletin for the delivery of medical conference highlights to physicians via email and the Web (for more on the history of the Electronic Highlights Bulletin, read “The Emerging Virtual Medical Conference”).

Link: http://www.news.pharma-mkting.com/ 


Pharmalicensing Logo JPG (600 x 120 pixels)

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.

Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


International Journal of Biomedical Engineering and Technology

European Prefilled Syringes Summit

IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).


International Journal of Biotechnology

0963-6048_IJBT

IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.

www.inderscience.com/ijbt


International Journal of Biomedical Nanoscience and Nanotechnology

1756-0799_IJBNN

IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.

www.inderscience.com/ijbnn


International Journal of Healthcare Technology and Management

1368-2156_IJHTM

JHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.

www.inderscience.com/ijhtm


International Journal of Medical Engineering and Informatics

1755-0653_IJMEI

IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.

www.inderscience.com/ijmei


International Journal of Biomedical Nanoscience and Nanotechnology

IJNBM

IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.

www.inderscience.com/ijbnn


GBI Logo0-02

GBI has been a trusted provider of value-added healthcare industry information, news, and data services since 2002. Founded in Shanghai, a diverse portfolio of market intelligence solutions enables organizations and individuals to make data-driven decisions and communicate more effectively.

GBI’s flagship data service, SOURCE, was launched in 2009 with DEVINT, METRIX and NAVIS now offering a diverse portfolio covering pharmaceutical and medtech markets in China and Latin America. The firm enjoys long-term, established partnerships with multinational players. Alongside these, GBI’s emerging markets news service provides authoritative and up-to-date intelligence on corporate developments, deals and partnering, R&D, and public policy.

GBI is headquartered in Shanghai, China, with offices in Beijing, and Washington D.C.

http://www.gbihealth.com


PharmaCircle_logo_1500px_wide

PharmaCircle is a leading provider of global information and analytics on drugs, biologics and combination products in all stages of development, delivering seamless integration of scientific, clinical, safety, regulatory, manufacturing and commercial information into one solution.  PharmaCircle connects product and pipeline information for drugs and biologics with formulation and component details, and provides expert analysis on drug delivery technologies and devices.  PharmaCircle’s multi-parameter search capabilities and layered analytics support the information needs of drug discovery, toxicology, pre-formulation, formulation design and development, process development and scale-up, and technology transfer.   Visit our website to see how we can help your company.

www.pharmacircle.com


THE PHARMA WORLD

THE PHARMA WORLD is the first and the only bi-monthly Pharmaceutical and Health Journal of its kind in Bangladesh catering to the needs of Pharmaceutical Industries, Physicians, Healthcare Providers, Indentors and all other stakeholders related to this sector. The Journal is also designed to disseminate information about the advancement of research & development in pharmaceutical sector and medical science, thereby constantly updating readers on this multi-dimensional segment. Besides this, THE PHARMA WORLD acts as representative of many reputed International event organizers worldwide. THE PHARMA WORLD represents a good number of international event organizers of the UK, India, Vietnam, Pakistan, South Korea, China, Singapore, South Africa, Kenya, Nigeria, Senegal, the UAE, Jordan, Syria, Sudan, Tanzania, Philippines, Malaysia, to name a few.

 THE PHARMA WORLD also has a Consultancy Division which is engaged in a wide range of activities which include Export Promotion, Bioequivalence Study, Market Survey, Training, and organizing seminar/workshop/conference on matters relating to the pharma sector.

http://www.thepharmaworld.com.bd/

Agenda Download

If you would like a copy of the brochure for this conference please complete the form below and click 'submit'.
  • This field is for validation purposes and should be left unchanged.